ICU Medical, Inc. (ICUI)

ICU Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	60.33	0.73	-117.69	-29.66	-74.29	103.14
Depreciation & Amortization	200.06	200.74	219.51	228.77	235.15	89.7
Other Amortization	3.46	6.18	6.81	6.81	6.97	0.24
Loss (Gain) From Sale of Assets	2.52	-38.89	2.52	2.11	2.01	1.65
Loss (Gain) From Sale of Investments	-	-	-	-	-	0.66
Loss (Gain) on Equity Investments	2.22	1.19	-	-	-	-
Stock-Based Compensation	51.62	55.76	46.88	40.56	36.03	27.34
Provision & Write-off of Bad Debts	-	-	-	-	1.04	0.35
Other Operating Activities	44.04	44.19	48.57	53.2	34.69	29.43
Change in Accounts Receivable	-24.62	8.88	-46.84	48.64	-19.15	13.76
Change in Inventory	12.28	-26.25	16.83	-6.08	-201.1	20.82
Change in Accounts Payable	-27.02	7	12.53	-68.3	37.47	2.35
Change in Income Taxes	-33.85	-24.76	26.23	-82.36	-66.73	0.87
Change in Other Net Operating Assets	-11.83	-54.91	-11.32	-27.5	-54.22	-22.75
Operating Cash Flow	279.24	179.85	204.03	166.2	-62.13	267.54
Operating Cash Flow Growth	75.14%	-11.85%	22.76%	-	-	20.11%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-70.65	-88.04	-79.37	-83.89	-90.31	-68.54
Sale of Property, Plant & Equipment	8.06	8.06	0.75	1.5	0.99	0.22
Cash Acquisitions	-	-	-	-	-1,844	-14.45
Divestitures	5.93	211.19	-	-	-	-
Sale (Purchase) of Intangibles	-7.01	-8.97	-10.83	-9.78	-9.02	-12.63
Investment in Securities	-	-	0.5	4.22	33.04	4.72
Investing Cash Flow	-63.67	122.23	-88.96	-87.95	-1,909	-90.69

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	0.31	-	-	1,664	-
Total Debt Issued	0.31	0.31	-	-	1,664	-
Long-Term Debt Repaid	-	-304.8	-52.15	-30.65	-23.06	-0.61
Total Debt Repaid	-167.16	-304.8	-52.15	-30.65	-23.06	-0.61
Net Debt Issued (Repaid)	-166.85	-304.49	-52.15	-30.65	1,641	-0.61
Issuance of Common Stock	0.62	6.11	10.94	4.02	8.79	9.37
Repurchase of Common Stock	-39.21	-8.77	-11.99	-9.35	-10.88	-8.34
Other Financing Activities	-4.38	-4.38	-2.6	-	-2.18	-17.3
Financing Cash Flow	-209.82	-311.53	-55.8	-35.98	1,637	-16.87

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-3.72	8.85	-4.93	3.16	-9.48	-3.25
Net Cash Flow	2.05	-0.6	54.34	45.44	-344.04	156.73

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	208.6	91.8	124.66	82.31	-152.44	199
Free Cash Flow Growth	189.87%	-26.36%	51.46%	-	-	52.20%
Free Cash Flow Margin	9.55%	4.11%	5.23%	3.64%	-6.69%	15.12%
Free Cash Flow Per Share	8.28	3.69	5.11	3.42	-6.39	9.14
Levered Free Cash Flow	246.35	393.45	75.8	162.25	-144.11	176.31
Unlevered Free Cash Flow	291.9	445.61	135.58	219.64	-106.83	176.6

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	83.74	83.74	99.72	95.91	63.71	0.86
Cash Income Tax Paid	-	-	25.25	35.81	27.5	19.56
Change in Working Capital	-85.02	-90.04	-2.57	-135.6	-303.73	15.04

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error